2 GLOBALCAUSE.CO.UK
AN INDEPENDENT SUPPLEMENT BY MEDIAPLANET
MEDIAPLANET
READ MORE ON GLOBALCAUSE.CO.UK
IN THIS ISSUE
Midwife’s account of battling against stigma. HIV-positive parents are refused care for their newborn baby P8
More stories on screening, preventative therapy and early treatment and how we can challenge HIV-related stigma, myths and discrimination
Loyce Maturu shares her experience: Supporter and Youth Ambassador turns her personal tragedy into global support P15
Why we need to quicken our pace to end AIDS Now is not the time to be complacent in the fight against HIV says Michel Sidibé, Executive Director of UNAIDS — the Joint United Nations Programme on HIV/AIDS.
G
reat strides have been cent increase in new HIV infections and looking at some of the challenges changed the nature of HIV. An made in the response to — and almost a 38 per cent increase in faced by people living with and affect- HIV-positive 20-year-old who is HIV over the last 15 years. AIDS-related deaths — since 2010. And ed by HIV. For example, worryingly, not receiving treatment has a life There has been an accel- while today, 70 per cent of all people one in five people living with HIV say expectancy of 29; whereas, with eration in HIV screening, preventive living with HIV know their HIV status they have faced discrimination in a treatment, that same person would have a normal life expectancy. Eartherapy and early treatment and a and 53 per cent have access to treathealthcare setting. breakthrough in antiretroviral thera- ment, western and central Africa lags To combat stigma and discrimi- ly detection and treatment can also py, management and comprehensive worryingly behind. nation, it’s critical to start involving reduce deaths from co-infection. long-term care. Also, AIDS-related Globally, there are 36.7 million peoand educating communities so that This is important because tuberdeaths have fallen by 48 per cent since ple living with HIV and 1.8 million knowledge, skills and competencies culosis remains the leading cause the peak of the epidemic in 2005, so new infections every year. This cannot can be effectively transferred. There- of death among people living with there may be a temptation to feel that be ignored. fore, we are calling for a network of HIV, accounting for around one in the threat has gone away and that two million community health work- three AIDS-related deaths. Michel Sidibé Be alert to complacency So, today of all days, I want to AIDS is over. ers across Africa by 2020. They will Executive Director, UNAIDS But the threat has not gone away. The greatest threat we face now is ensure that people receive early HIV stress that everyone has the right And AIDS is most definitely not over. complacency. We must not lose our testing and treatment services and to health and the right to access HIV TRIALS NETWORK Abbreviated usage, Website andreference Print HIV NETWORK Abbreviated Style Guide for HVTNpeople’s Logo usage, Website and Print materials.HIV services, including the marIn VACCINE fact, it is still heartbreakingly evi-VACCINE sense of TRIALS urgency when it comes to Style Guide reference for HVTN Logo canmaterials. change perspective about Graphic elements should be void of gradientsGraphic or drop elements shadows should (“flat” design). be void of (“flat” design). dent in every part of the worldBRAND and in ginalised and most vulnerable in responding to HIV. Indeed, we must what itgradients meansortodrop be shadows HIV positive. BRAND GUIDELINES GUIDELINES For questions, please contact the HVTN Communications info@hvtn.org. For questions,Unit, please contact the HVTN Communications Unit, info@hvtn.org. some places instances are increasing. society. By reaching people most quicken our pace so that organisa2017 2017 Early detection and affected by HIV we can end this tions, businesses and communities AIDS increasing in Eastern treatment can reduce epidemic. work better together to save more Europe and Central Asia AIDS-related deaths We have achieved so much. Now lives. Take Eastern Early diagnosis is key because, we need to go the extra mile and On this year’s World AIDSLOGO Day,WEB we PRIMARY LOGOEurope and Central LOGO VARIATIONS T YPOGRAPHY PRIMARY LOGO VARIATIONS WEB T YPOGRAPHY Asia, which has recorded a 60 per are highlighting the right to health today, treatment has completely end AIDS.
“An HIV positive 20-year-old who is not receiving treatment has a life expectancy of 29”
AFollow
us
B facebook.com/MediaplanetUK B
A
ABCDe ABCDe H1/BOOKH1/BOOK FGHIJK FGHIJK H2/BOOK H2/BOOK 012345 012345 H3/MEDIUM H3/MEDIUM !@£%& !@£%& @MediaplanetUKNOVECENTO
WIDE Font NOVECENTO WIDE Font @MediaplanetUK
www.fontsquirrel.com/fonts/novecento-widewww.fontsquirrel.com/fonts/novecento-wide
Please recycle
Senior Project Manager: Charlotte Platt E-mail: charlotte.platt@mediaplanet.com Content and Production Manager: Kate Jarvis Senior Account Manager and Video Lead: Sandy SY Lee Managing Director: Alex Williams Content and Social Editor: Jenny Hyndman Designer: Juraj Prikopa Junior Designer: Mushada Raquib Mediaplanet contact information: Phone: +44 (0) 203 642 0737 E-mail: info.uk@mediaplanet.com C
C
HIV VACCINE DTRIALS NETWORK / DFRED HUTCHINSON CANCER RESEARCH CENTER
HVTN_Logo_Color_Square.eps HVTN_Logo_Color_Horiz.eps B.
HVTN_Logo_Greyscale_Square_LtBg.eps HVTN_Logo_Color_Square.eps HVTN_Logo_Color_Horiz.eps
https://www.fontsquirrel.com/fonts/museo-slab https://www.fontsquirrel.com/fonts/museo-slab
01234
we have concurrent efficacy trials underway, which will collectively enroll Italicfour [500] Italic [500] 01234 01234 01234 12,200 volunteers in the search for an HIV vaccine,” notes Dr. Lawrence corey,
!@£%&
HVTN Principal Investigator. Bold [900] !@£%& !@£%& !@£%&
HVTN_Logo_Greyscale_Square_LtBg.eps
As the world’s largest publicly international collaboration D. 1-Color Version funded multi-disciplinary D. 1-Color Version Full Color Version, reversed Usage: Giveaway/Promo Items to prevent Full Color Version, reversed Usage: Giveaway/Promo facilitating theB. development of vaccines HIV/AIDS, Items HVTN conducts Usage: Black/Dark Backgrounds HVTN_Logo_1-Color_Square.eps Usage: Black/Dark Backgrounds HVTN_Logo_1-Color_Square.eps all phases of clinical trials, from evaluating experimental vaccines for safety and HVTN_Logo_Color_Square_DkBg.eps HVTN_Logo_Color_Square_DkBg.eps immunogenicity to testing vaccine efficacy.
SOCIAL BUTTONS ICONS
COLOR PALETTE BUTTONS
COLOR PALETTE
DEEP BLUE
FACEBOOK.COM/HELPENDHIV
? ?
CMYK: C=78 M=34 Y=26 K=1 RGB: R=53 G=137 B=165 Web: #3589a5 questions about HVTN.ORG
questions about TWITTER.COM/HELPENDHIV hiv testing & visp hiv testing & visp
?
submit your research idea
?
PERSIMMON CMYK: C=8 M=91 Y=100 K=1 submit your R=220 G=59 B=15 research RGB: idea Web: #dc3b0f
Bold [900]
The HVTN recognizes the importance of public support in finding a vaccine against HIV/ AIDS. Staff and volunteers from around the globe work actively to help community members understand the science of HIV/AIDS vaccines, as well as research methods and clinical trial processes. Dr. Glenda Gray, HVTN co-pi and director of HVTN Africa Programs highlights “We recognize the importance of community stakeholders in developing improved approaches to HIV-1 prevention.”
The HVTN is known for its collaborations from a diverse set of stakeholders. It has established both a clinical trial and laboratory platform for the independent evaluation of candidate HIV vaccines, and allowing for reliable assessments across trials, setting statistical standards for the field, and actively engaging with over 40 site communities on
SOCIAL ICONS
H4/MEDIUM
MUSEO SLAB FONT MUSEO SLAB FONT AaBb AaBb AaBb five continents.AaBb These achievements have allowed the HVTN to conduct over 80 clinical trials and make numerous scientific contributions to the field. Body Text/Link [500] Body Text/Link [500] CcDd CcDd CcDd “Currently weCcDd are in the midst of an unprecedented time in HIV vaccine research:
USAGE Researchers atLOGO the HIV Vaccine Trials Network (HVTN) are working toward the goal of welcoming an AIDS-free generation by developing an effective, global vaccine to Full Color Version (Primary) C. Greyscale Version A. Full Color Version (Primary) C. Greyscale Version prevent HIV/AIDS. Usage: White/Light Backgrounds Usage: Black & White Print Usage: White/Light Backgrounds Usage: Black & White Print
LOGO USAGE A.
H4/MEDIUM
DEEPGREY BLUEBLUE
GREY BLUE
CMYK:CMYK: C=78 C=58 M=34M=35 Y=26 Y=36 K=1 K=3 RGB: R=117 RGB: R=53 G=137G=42 B=165B=149 Web: #758e95 Web: #3589a5
CMYK: C=58 M=35 Y=36 K=3 RGB: R=117 G=42 B=149 Web: #758e95
LIGHT BLUE PERSIMMON
LIGHT BLUE
C=54Y=100 M=1 Y=7 CMYK:CMYK: C=8 M=91 K=1K=0 RGB: R=100 RGB: R=220 G=59G=201 B=15 B=229 Web: #64c9e5 Web: #dc3b0f
CMYK: C=54 M=1 Y=7 K=0 RGB: R=100 G=201 B=229 Web: #64c9e5